Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer
Joint Authors
Fawzi, Amal
Jafar, Rabab
Qasim, Fatima
Ali, Shawqi S.
al-Shafii, Mustafa
al-Dib, Mahmud
Source
Journal of the Egyptian National Cancer Institute
Issue
Vol. 24, Issue 1 (31 Mar. 2012), pp.41-45, 5 p.
Publisher
Cairo University National Cancer Institute
Publication Date
2012-03-31
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Topics
Abstract EN
Background : angiogenesis is an essential process in cancer growth maintenance, and metastasis.
Angiopoietin-2 promotes tumor angiogenesis by priming the vasculature and potentiating the effects of cytokines at the front of active neovascularization.
Enhanced expression of angiopoietin-2 has been reported in lung cancer tissue.
Surviving is one of the inhibitors of apoptosis protein that has been shown to play a key role in cancer progression, and in tumor angiogenesis.
Also plays a key role in tumor cell resistance to anticancer agents and ionizing radiation.
Aim : to measure the serum levels of angiopoietin-2 and surviving as possible antigenic factors in lung cancer patients with the assessment of their interrelationships and clinical significance.
Patients and methods: Patients with lung cancer as NSCLC (n= 70) and healthy volunteers (n= 10) were enrolled.
Serum angiopoietin-2 and surviving concentrations were measured using enzyme-linked immunosorbent assay (ELIZA).
Results : Median serum angiopoietin-2 levels with lung cancer (2730 pg / mL) ranged from 1171 to 6541 pg / mL was higher than the median of the control group (1795 pg / mL) ranged from 1076 to 2730 / mL, p< 0.001.
Median serum surviving levels were also higher in patients with lung cancer (35.0 pg / mL) ranged from 39.3 to 96.3 pg / mL than the median of the control group (48.8 pg / mL) ranged from 38.0 to 74.6 pg / mL, but did not reach statistical significance p = 0.206.
In all patients with lung cancer, serum angiopoietin-2 was not significantly correlated with surviving (r = 0.073, p = 0.657).
Neither serum angiopoietin-2 nor surviving showed significant relation with the serum angiopoietin-2 or surviving levels depending on the cell types, stage progression, and metastasis among the patients with NSCLC.
Conclusions : our study suggests that serum angiopoietin-2 is a useful marker for the diagnosis of NSCLC by ELIZA technique.
American Psychological Association (APA)
Fawzi, Amal& Jafar, Rabab& Qasim, Fatima& Ali, Shawqi S.& al-Shafii, Mustafa& al-Dib, Mahmud. 2012. Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer. Journal of the Egyptian National Cancer Institute،Vol. 24, no. 1, pp.41-45.
https://search.emarefa.net/detail/BIM-312833
Modern Language Association (MLA)
Fawzi, Amal…[et al.]. Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer. Journal of the Egyptian National Cancer Institute Vol. 24, no. 1 (Mar. 2012), pp.41-45.
https://search.emarefa.net/detail/BIM-312833
American Medical Association (AMA)
Fawzi, Amal& Jafar, Rabab& Qasim, Fatima& Ali, Shawqi S.& al-Shafii, Mustafa& al-Dib, Mahmud. Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer. Journal of the Egyptian National Cancer Institute. 2012. Vol. 24, no. 1, pp.41-45.
https://search.emarefa.net/detail/BIM-312833
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 45
Record ID
BIM-312833